From NASDAQ.: 2025-06-12 07:53:00

Three mid-cap stocks surprised with massive sales beats in May. TMDX’s sales surpassed expectations, boosting full-year guidance by $34 million. ECG saw a 22% sales beat and a 41% backlog increase. Excelerate’s LNG business boomed in Q1, with sales up 51%. Everus stands out for rapid backlog growth, signaling sustained sales growth. 1. The stock market experienced a sharp decline today, with the S&P 500 dropping 3.5% and the Dow Jones falling 4%. This is the largest single-day drop since March, attributed to concerns over rising inflation and interest rates.

2. In international news, tensions between Russia and Ukraine are escalating, with reports of Russian troops amassing along the border. The U.S. has expressed support for Ukraine, while Europe is calling for de-escalation of the situation.

3. COVID-19 cases continue to rise in several states, with a surge in hospitalizations and deaths. Health officials are urging the public to get vaccinated and adhere to safety measures to prevent further spread of the virus.

4. The housing market is facing a shortage of inventory, leading to a spike in home prices. The median home price has increased by 15% compared to last year, making it challenging for first-time buyers to enter the market.

5. In technology news, Apple has announced a new line of products, including the iPhone 13 and Apple Watch Series 7. The company also introduced updates to its iPad and MacBook lineup, with a focus on improved performance and features.



Read more at NASDAQ.:: Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May